Juvenile Idiopathic Arthritis
Condition
(JIA; Juvenile Rheumatoid Arthritis; JRA; Juvenile Chronic Polyarthritis; Stills Disease)
Definition
Juvenile idiopathic arthritis (JIA) is joint stiffness and swelling in children. It can make it painful to move. Early treatment can improve outcomes.
There are five major types:
- Pauciarticular—four or less joints are affected
- Polyarticular—five or more joints are affected
- Enthesitis—arthritis with swelling of the tissue where a bone meets a tendon or ligament
- Psoriatic—arthritis and a skin disease called psoriasis
- Systemic—affects the entire body (not common)
Copyright © Nucleus Medical Media, Inc.

Causes
JIA is caused by a problem with the immune system. The normal job of the immune system is to find and destroy things that should not be in the body, such as viruses. With JIA, the immune system attacks and damages healthy tissue in the joint. It is not known why this happens. Genetics and the environment may play a role.
Risk Factors
JIA is more common in girls.
There are no clear risk factors for JIA. A family history of these health problems may be linked to some types of JIA:
Symptoms
A child may have times when symptoms are worse and times when they improve. Symptoms may not be the same in each child. They can also differ with each type of JIA.
Some common problems may be:
- Joint pain or stiffness, especially in the morning or after rest
- Red, swollen, or warm joints
- Lack of energy
- Vision problems
- Rash
- Lack of hunger
- Fever
Diagnosis
The doctor will ask about the child’s symptoms and past health. A physical exam will be done. It will focus on the joints. An eye exam may also be done.
Blood tests will be done to look for proteins and chemicals linked to JIA.
Pictures of the joints may be taken. This can be done with:
Treatment
There is no cure. The goal of treatment is to manage symptoms, slow the disease, and prevent damage. Choices are:
- Physical therapy and regular exercise to promote strength, flexibility, and range of motion
- Assistive devices like splints to support bone and joint growth
- Medicines, such as:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) to ease pain and swelling
- Corticosteroids to ease swelling
- Tumor necrosis factor (TNF) blockers to decrease swelling, pain, and joint stiffness
- Disease-modifying antirheumatic drugs (DMARDs) to slow the disease
- Interleukin inhibitors to ease disease activity
Prevention
There are no known guidelines to prevent JIA.
American College of Rheumatology
Arthritis Foundation
CANADIAN RESOURCES:
The Arthritis Society
Health Canada
American College of Rheumatology
Arthritis Foundation
CANADIAN RESOURCES:
The Arthritis Society
Health Canada
References
- Juvenile idiopathic arthritis (JIA) enthesitis related. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/juvenile-idiopathic-arthritis-jia-enthesitis-related.
- Juvenile idiopathic arthritis (JIA) oligoarticular. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/juvenile-idiopathic-arthritis-jia-oligoarticular.
- Juvenile idiopathic arthritis (JIA) polyarticular. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/juvenile-idiopathic-arthritis-jia-polyarticular.
- Juvenile idiopathic arthritis (JIA) systemic-onset. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/juvenile-idiopathic-arthritis-jia-systemic-onset.
- Ringold S, Angeles-Han ST, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res (Hoboken). 2019 Jun;71(6):717-734.
Contributors
- Nicole S. Meregian, PA
(C) Copyright 2023 EBSCO Information Services
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com.